slight advantages of nimotuzumab versus cetuximab plus concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma. (2019).
本文档由 崔亚杰 分享于2019-08-27 19:05
slight advantages of nimotuzumab versus cetuximab plus concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma. (2019).
分享:
君,已阅读到文档的结尾了呢~~